Novozymes announced completion of the acquisition of Canada-based Philom Bios. The inoculant company will become the cornerstone of Novozymes’ BioAgriculture business.
“This is a strategy we have been developing since the beginning of 2006 when we planned our entry into the organic and sustainable agriculture market,” said Novozymes Biologicals’ President Ted Melnik.
Using technologies developed in Salem, Va, Novozymes will expand Philom Bios’ current market presence in the agricultural segment. The merger provides future opportunities for growth of Novozymes in Salem; however, no immediate changes are planned. Philom Bios will continue to do business from Saskatoon, Canada and Novozymes Biologicals’ existing business will remain in Salem.
“We are committed to establishing Novozymes as a leader in the sustainable agriculture industry, providing earth-friendly alternatives to traditional pesticides and fertilizers,” Melnik explained. “This merger reinforces that commitment.”
Latest from Lawn & Landscape
- Massey Services promotes Mumme to divisional VP, commercial services regio
- Asplundh Infrastructure Group promotes MacAleese to COO
- Caterpillar's Umpleby III to retire as executive chairman of board
- Breaking down the HighGrove Partners sale to Agellus Capital
- Registration open for the Lawn & Landscape Technology Conference
- OTR Engineered Solutions names Oscar Torres president, CEO
- The rules of M&A are changing
- Our top stories of 2025